Search
for
Sort by
Research 241–270 of 253
- Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Hair-thread tourniquet syndrome in a preterm baby
- Impacts of COVID-19 Pandemic on Dermatology Outpatient Department at a Tertiary Hospital in Eastern China: A Pre-Post Study
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Dermatoses in Postmenopausal Women in a Tertiary Health Care Center of Bihar: A Prospective Cross-Sectional Study
- Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study
- Acrodermatitis Enteropathica in an adult: a case report
- Community-Acquired MRSA
- Sterile matrix grafting for onycholysis in the setting of valproic acid use
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)
- Onychomatricoma: Clinical presentation and management
- Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- ACUTE ZINC DEPLETION SYNDROME DURING PARENTERAL HYPERALIMENTATION
- Mucocutaneous reactions to chemotherapy
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Oral retinoids-present status
- Alternative uses of dermoscopy in daily clinical practice: An update
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture